Pharmacological blockage of CXCR2 by SB225002 significantly prevented and suppressed the development of AF, likely by inhibiting the hypertension‐induced recruitment of macrophages into the atria and oxidative stress in SHRs. The gene discussed is CXCR2; the disease is atrial fibrillation.